View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsECMOHO 배당 및 자사주 매입배당 기준 점검 0/6핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공지 • Nov 06ECMOHO Limited Provides Earnings Guidance for the Third Quarter of 2022ECMOHO Limited provided earnings guidance for the third quarter of 2022. For the quarter, The company expects that the net loss will decrease in the third quarter of 2022, compared with the same quarter of last year.공지 • Oct 27Nasdaq Stock Market to Delist the American Depositary Shares of Ecmoho LimitedOn October 26, 2022, Nasdaq Stock Market announced that it will delist the American Depositary Shares of ECMOHO Limited. ECMOHO Limited’s securities were suspended on September 23, 2022, and have not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting become effective ten days after the Form 25 is filed.Board Change • Jul 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Feb 26Now 97% undervalued after recent price dropOver the last 90 days, the stock is down 100%. The fair value is estimated to be US$0.016, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 33% per annum over the last 3 years.Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$28.3m (down 61% from 3Q 2020). Net loss: US$3.75m (loss narrowed 9.0% from 3Q 2020). Revenue was in line with analyst estimates.공지 • Sep 23ECMOHO Limited Announces Receipt of Minimum Bid Price Notice from NasdaqECMOHO Limited announced that it received a notification letter dated September 16, 2021 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”), indicating that the Company is no longer in compliance with the minimum bid price requirement set forth in Rule 5450(a)(1) of the Nasdaq Listing Rules as the Company’s closing bid price per American depositary share (“ADS”), each representing four Class A ordinary shares, par value $0.00001 per share, of the Company, has been below $1.00 for a period of 30 consecutive business days. The Nasdaq notification letter does not result in the immediate delisting of the Company's securities. Pursuant to Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until March 15, 2022 (the “Compliance Period”), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per ADS is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event that the Company does not regain compliance by March 15, 2022, subject to the determination by the staff of Nasdaq, it may be eligible for an additional 180 calendar days compliance period if it meets the continued listing requirements for market value of publicly held shares and all other initial listing standards, with the exception of bid price requirement, of the Nasdaq Capital Market, and provides written notice to Nasdaq of its intention to cure the deficiency.공지 • Sep 02ECMOHO Limited Provides Preliminary Earnings Guidance for the Third Quarter of 2021ECMOHO Limited provided preliminary earnings guidance for the third quarter of 2021. For the quarter, the company expects net loss to be significantly decrease.Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a soft second quarter result with weaker revenues and control over costs, although losses reduced. Second quarter 2021 results: Revenue: CN¥42.8m (down 94% from 2Q 2020). Net loss: CN¥3.56m (loss narrowed 89% from 2Q 2020).공지 • Aug 05ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million.ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 10,000,000 Price\Range: $0.9 Discount Per Security: $0.063Reported Earnings • Jun 05First quarter 2021 earnings releasedThe company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: US$27.1m (down 56% from 1Q 2020). Net loss: US$6.07m (loss widened 38% from 1Q 2020).공지 • May 18Ecmoho Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement ProductECMOHO Limited announced that on May 10, 2021, a new product, Puxue Oral Liquid, which is a supplement intended for use by children aged between one and 17, adults, pregnant women, and nursing mothers who suffer from iron and vitamin B12 deficiencies, is jointly launched by the Company and Harbin Pharmaceutical Group Co. Ltd. (“HPGC”). ECMOHO is primarily responsible for the packaging design and sales distribution of the new product.Reported Earnings • May 03Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: US$304.9m (down 7.4% from FY 2019). Net loss: US$13.3m (down US$14.3m from profit in FY 2019).지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 0NE 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 0NE 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장ECMOHO 배당 수익률 vs 시장0NE의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (0NE)n/a시장 하위 25% (DE)0%시장 상위 25% (DE)0%업계 평균 (Online Retail)0%분석가 예측 (0NE) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 0NE 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 0NE 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 0NE 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 0NE 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/03/07 15:06종가2022/12/14 00:00수익2022/06/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스ECMOHO Limited는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공지 • Nov 06ECMOHO Limited Provides Earnings Guidance for the Third Quarter of 2022ECMOHO Limited provided earnings guidance for the third quarter of 2022. For the quarter, The company expects that the net loss will decrease in the third quarter of 2022, compared with the same quarter of last year.
공지 • Oct 27Nasdaq Stock Market to Delist the American Depositary Shares of Ecmoho LimitedOn October 26, 2022, Nasdaq Stock Market announced that it will delist the American Depositary Shares of ECMOHO Limited. ECMOHO Limited’s securities were suspended on September 23, 2022, and have not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting become effective ten days after the Form 25 is filed.
Board Change • Jul 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Fang Yuan was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Feb 26Now 97% undervalued after recent price dropOver the last 90 days, the stock is down 100%. The fair value is estimated to be US$0.016, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 33% per annum over the last 3 years.
Reported Earnings • Dec 01Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: US$28.3m (down 61% from 3Q 2020). Net loss: US$3.75m (loss narrowed 9.0% from 3Q 2020). Revenue was in line with analyst estimates.
공지 • Sep 23ECMOHO Limited Announces Receipt of Minimum Bid Price Notice from NasdaqECMOHO Limited announced that it received a notification letter dated September 16, 2021 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”), indicating that the Company is no longer in compliance with the minimum bid price requirement set forth in Rule 5450(a)(1) of the Nasdaq Listing Rules as the Company’s closing bid price per American depositary share (“ADS”), each representing four Class A ordinary shares, par value $0.00001 per share, of the Company, has been below $1.00 for a period of 30 consecutive business days. The Nasdaq notification letter does not result in the immediate delisting of the Company's securities. Pursuant to Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until March 15, 2022 (the “Compliance Period”), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per ADS is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event that the Company does not regain compliance by March 15, 2022, subject to the determination by the staff of Nasdaq, it may be eligible for an additional 180 calendar days compliance period if it meets the continued listing requirements for market value of publicly held shares and all other initial listing standards, with the exception of bid price requirement, of the Nasdaq Capital Market, and provides written notice to Nasdaq of its intention to cure the deficiency.
공지 • Sep 02ECMOHO Limited Provides Preliminary Earnings Guidance for the Third Quarter of 2021ECMOHO Limited provided preliminary earnings guidance for the third quarter of 2021. For the quarter, the company expects net loss to be significantly decrease.
Reported Earnings • Sep 01Second quarter 2021 earnings releasedThe company reported a soft second quarter result with weaker revenues and control over costs, although losses reduced. Second quarter 2021 results: Revenue: CN¥42.8m (down 94% from 2Q 2020). Net loss: CN¥3.56m (loss narrowed 89% from 2Q 2020).
공지 • Aug 05ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million.ECMOHO Limited has completed a Follow-on Equity Offering in the amount of $9 million. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 10,000,000 Price\Range: $0.9 Discount Per Security: $0.063
Reported Earnings • Jun 05First quarter 2021 earnings releasedThe company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: US$27.1m (down 56% from 1Q 2020). Net loss: US$6.07m (loss widened 38% from 1Q 2020).
공지 • May 18Ecmoho Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement ProductECMOHO Limited announced that on May 10, 2021, a new product, Puxue Oral Liquid, which is a supplement intended for use by children aged between one and 17, adults, pregnant women, and nursing mothers who suffer from iron and vitamin B12 deficiencies, is jointly launched by the Company and Harbin Pharmaceutical Group Co. Ltd. (“HPGC”). ECMOHO is primarily responsible for the packaging design and sales distribution of the new product.
Reported Earnings • May 03Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: US$304.9m (down 7.4% from FY 2019). Net loss: US$13.3m (down US$14.3m from profit in FY 2019).